Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Sanofi-Aventis Sa (NYSE: SNY)

$49.00 USD -$0.03 (-0.06%)
Last Price $49
Net Change $-0.03 (-0.06%)
Bid $0
Ask Price $0
Open Price $48.98
Previous Close Price $49.03
High Price $49.18
Low Price $48.85
Number of Trades 2,528
Volume 1,071,000
Fifty Two Week High $50.24 (2017-05-16)
Fifty Two Week Low $36.81 (2016-10-26)
Average Daily Volume 1,785,553
Share Outstanding 2,543,800 Shares
Total Dividend Payout 1.05/yr
Dividend Yield 2.15%
1st Quarter Earnings $1.42 (2017-04-28)
2nd Quarter Earnings $1.25 (2017-02-08)
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $15.47
EPS Growth $-2.22
Recent Earnings $1.42
Annual EPS $3.17
Last Quarter EPS $
Market Capitalization $124.65B
Insider Shareholders % 0.01%
Annual Revenue $0B
No. Shares Outstanding 2,543,800
Inst. Shareholder % 9.86%
Annual Net Income $10.1B
TTM Net Profit Margin $13.11
1-Year Return 21.33%
3-Year Return 0.36%
5-Year Return 65.23%
5-Year Revenue Growth -21.34%
5-Year Earnings Growth -27.75%
5-Year Dividend Growth -18.25%
Annual Dividend $1.05
Annual Dividend Yield 2.15%
Change in EPS YTD -2.22%
Dividends per Share $1.054
Stock Split Ratio
Beta 1
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.